You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

OXAZEPAM - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for oxazepam and what is the scope of patent protection?

Oxazepam is the generic ingredient in three branded drugs marketed by Actavis Elizabeth, Am Therap, Epic Pharma Llc, Ivax Sub Teva Pharms, Mylan, Trupharma, Watson Labs, Watson Labs Teva, Alpharma Us Pharms, Quantum Pharmics, Parke Davis, and Sun Pharm Industries, and is included in twenty-four NDAs. Additional information is available in the individual branded drug profile pages.

There are eight drug master file entries for oxazepam. Four suppliers are listed for this compound.

Summary for OXAZEPAM
Drug Prices for OXAZEPAM

See drug prices for OXAZEPAM

Recent Clinical Trials for OXAZEPAM

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Assistance Publique - Hôpitaux de ParisPhase 2
Rose Research Center, LLCPhase 1/Phase 2
Foundation for a Smoke-Free WorldPhase 1/Phase 2

See all OXAZEPAM clinical trials

Pharmacology for OXAZEPAM
Drug ClassBenzodiazepine
Medical Subject Heading (MeSH) Categories for OXAZEPAM
Anatomical Therapeutic Chemical (ATC) Classes for OXAZEPAM

US Patents and Regulatory Information for OXAZEPAM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ivax Sub Teva Pharms OXAZEPAM oxazepam CAPSULE;ORAL 070944-001 Aug 3, 1987 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sun Pharm Industries OXAZEPAM oxazepam TABLET;ORAL 070683-001 Jan 16, 1987 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Parke Davis OXAZEPAM oxazepam TABLET;ORAL 071508-001 Feb 2, 1987 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for OXAZEPAM

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Alpharma Us Pharms SERAX oxazepam CAPSULE;ORAL 015539-002 Approved Prior to Jan 1, 1982 ⤷  Sign Up ⤷  Sign Up
Alpharma Us Pharms SERAX oxazepam CAPSULE;ORAL 015539-006 Approved Prior to Jan 1, 1982 ⤷  Sign Up ⤷  Sign Up
Alpharma Us Pharms SERAX oxazepam CAPSULE;ORAL 015539-004 Approved Prior to Jan 1, 1982 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.